MANAGEMENT OF BURNING MOUTH SYNDROME: A LITERATURE REVIEW

I Nyoman Gede Juwita Putra*  -  Universitas Padjadjaran, Indonesia
Riani Setiadhi  -  Universitas Padjadjaran, Indonesia

(*) Corresponding Author
DOI: 10.30659/odj.6.1.43-50
Background: Burning mouth syndrome (BMS) is a chronic idiopathic oral dysaesthesia that presents as a burning sensation in the oral cavity usually without any specific oral lesions or laboratory findings. Burning sensations may appear on the buccal mucosa, hard and soft palate, tongue and lips. BMS appears to be more prevalent in postmenopausal women. The term menopause is often used for a condition in which the permanent cessation of the primary function of the ovaries in humans that occurs especially in middle-aged women. Available evidence suggested that BMS is a multifactorial disorder with physiological basis. Pathophysiology of BMS remains unclear. The etiopathogenesis in most patients who complain of burning sensations have interactions with several factors such as local, systemic, and/ or psychogenic factors. The aim of this literature review was to assess and evaluate the management of BMS comprehensively.
Discussion: The therapy of BMS including hormone replacement therapy,
systemically therapy, such as antidepressants, clonazepam and topical medication (clonidine and capsaicin) and reassurance as the stress management.
Conclusion: Proper management of the BMS involves the combination of pharmacologic treatment and psychotherapy, as well as reassurance is an important thing

Keywords: Burning Mouth Syndrome; Management; Postmenopausal women

  1. Abetz L, Savage N. Burning mouth syndrome and psychological disorders. Aust Dent J. 2009;54(2):84-93. doi:10.1111/j.1834-
  2. 2009.01099.x.
  3. Shivpuri A, Sharma S, Trehan M, Gupta N. Burning mouth syndrome: A comprehensive review of literature. Asian J Oral Maxillofac Surg. 2011;23(4):161-166. doi:10.1016/j. ajoms.2011.06.002.
  4. Ueda N, Kodama Y, Hori H, et al. Two cases of burning mouth syndrome treated with olanzapine. Psychiatry Clin Neurosci. 2008;62(3):359-361. doi:10.1111/j.1440-1819.2008.01806.x.
  5. Gao J, Chen L, Zhou J, Peng J. A case-control study on etiological factors involved in patients with burning mouth syndrome. J Oral Pathol Med. 2008;38(1):24-28. doi:10.1111/j.1600-0714.2008.00708.x.
  6. Barker KE, Batstone MD, Savage NW. Comparison of treatment modalities in burning mouth syndrome. Aust Dent J. 2009;54(4):300-305. doi:10.1111/j.1834-7819.2009.01154.x.
  7. Sun A, Wu K-M, Wang Y-P, Lin H-P, Chen H-M, Chiang C-P. Burning mouth syndrome: a review and update. J Oral Pathol Med. 2013;42(9):649-655. doi:10.1111/jop.12101.
  8. Aravindhan R, Vidyalakshmi S, Kumar M, Satheesh C, Balasubramanium Am, Prasad Vs. Burning mouth syndrome: A review on its diagnostic and therapeutic approach. J Pharm Bioallied Sci. 2014;6(5):21. doi:10.4103/0975-7406.137255.
  9. Lopez-Jornet P, Camacho-Alonso F, Andujar-Mateos P, Sanchez-Siles M, Gomez-Garcia F. Burning mouth syndrome: An update. Med Oral Patol Oral y Cir Bucal. 2010;15(4):e562-e568.
  10. doi:10.4317/medoral.15.e562.
  11. Ko JY, Kim MJ, Lee SG, Kho HS. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS). Arch Gerontol Geriatr. 2012;55(3):755-761. doi:10.1016/j.archger.2011.10.001.
  12. Parveen Dahiya, Reet Kamal, Mukesh Kumar, Niti, Rajan Gupta KC. Burning Mouth Syndrome and Menopause. 2013:15-20.
  13. Klasser GD, Fischer DJ, Epstein JB. Burning Mouth Syndrome: Recognition, Understanding, and Management. Oral Maxillofac Surg ClinNorth Am. 2008;20(2):255-271. doi:10.1016/j.coms.2007.12.012.
  14. Torgerson RR. Burning Mouth Syndrome. Dermatol Ther. 2010;23(3):291-298. doi:10.1111/j.1529-8019.2010.01325.x.
  15. Farronato G, Maspero C. Menopause: Changes in The Mouth Cavity and Preventive Strategies. J Womens Heal Care. 2012;1(1):1-4. doi:10.4172/2167-0420.1000102.
  16. Kohorst JJ, Bruce AJ, Torgerson RR, Schenck LA, Davis MDP. A population-based study of the incidence of burning mouth syndrome. Mayo Clin Proc. 2014;89(11):1545-1552. doi:10.1016/j. mayocp.2014.05.018.
  17. De Souza FTA, Teixeira AÔL, Amaral TMP, et al. Psychiatric disorders in burning mouth syndrome. J Psychosom Res. 2012;72(2):142-146. doi:10.1016/j.jpsychores.2011.11.008.
  18. Luciano A de C and RFR-R. The Effect of Clonazepam Mouthwash on the Symptomatology of Burning Mouth Syndrome : An Open Pilot Study. 2014:2164-2167.
  19. Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, Ughetto S, Woda A. Effect of lingual nerve block on burning mouth syndrome
  20. (stomatodynia): A randomized crossover trial. Pain.2010;149(1):27-32. doi:10.1016/j. pain.2009.11.016.
  21. Stuginski-Barbosa J, Rodrigues GGR, Bigal ME, Speciali JG. Burning mouth syndrome responsive to pramipexol. J Headache Pain. 2008;9(1):43- 45. doi:10.1007/s10194-008-0003-4.
  22. López-Jornet P, Camacho-Alonso F, Molino-Pagan D. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome. J Oral Pathol Med. 2013;42(4):295-301. doi:10.1111/jop.12002.
  23. Silvestre FJ, Silvestre-Rangil J, Tamarit-Santafé C, Bautista D. Application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2012;17(1):2-5. doi:10.4317/medoral.17219.
  24. Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope. 2012;122(4):813-816. doi:10.1002/lary.22490.
  25. Lopez-D alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: A randomized, double-blind, placebo controlled trial. Med Oral Patol Oral y Cir Bucal. 2011;16(5):635-640. doi:10.4317/medoral.16942.
  26. Hugoson A, Thorstensson B. Vitamin b status and response to replacement therapy in patients with burning mouth syndrome. Acta Odontol Scand. 2015;49(6):367-375. doi:10.3109/00016359109005933.
  27. Rodriguez-Cerdeira. Treatment of Burning Mouth Syndrome With Amisulpride. J Clin Med Res. 2012. doi:10.4021/jocmr972w.
  28. Cho GS, Han MW, Lee B, et al. Zinc deficiency may be a cause of burning mouth syndrome as zinc replacement therapy has therapeutic effects. J Oral Pathol Med. 2010;39(9):722-727. doi:10.1111/j.1600-0714.2010.00914.x.
  29. Meurman JH, Tarkkila L, Tiitinen A. The menopause and oral health. Maturitas. 2009;63(1):56-62. doi:10.1016/j.maturitas.2009.02.009.
  30. Gass MLS, Manson JE, Cosman F, et al. The
  31. hormone therapy position statement of the North American Menopause Society. Menopause. 2012;19(3):257-271. doi:10.1097/gme.0b013e31824b970a.
  32. de Castro LA, Ribeiro-Rotta RF. The effect of clonazepam mouthwash on the symptomatology of burning mouth syndrome: An open pilot study. Pain Med (United States). 2014;15(12):2164-2166. doi:10.1111/pme.12552.
  33. Brailo V, Firić M, VuÄićević Boras V, Andabak Rogulj A, Krstevski I, Alajbeg I. Impact of reassurance on pain perception in patients with primary burning mouth syndrome. Oral Dis. 2016;22(6):512-516. doi:10.1111/odi.12493.
  34. Quartana PJ, Campbell CM, Edwards RR. Pain
  35. catastrophizing a critical review. Expert Rev Neurother. 2009;9(5):745-758. doi:10.1586/ern.09.34.
  36. Schütze R, Rees C, Preece M, Schütze M. Low mindfulness predicts pain catastrophizing in a fear-avoidance model of chronic pain. Pain. 2010;148(1):120-127. doi:10.1016/j. pain.2009.10.030.
  37. Matsuoka H, Himachi M, Furukawa H, et al. Cognitive profile of patients with burning mouth syndrome in the Japanese population. Odontology. 2010;98(2):160-164. doi:10.1007/s10266-010-0123-6.

Lisensi Creative Commons
This work is licensed under a Lisensi Creative Commons Atribusi-BerbagiSerupa 4.0 Internasional.
Contact us: Odonto Dental Journal: Jl. Raya Kaligawe Km.4, PO BOX 1054/SM Semarang, Central Java, Indonesia, 50112. Email: odontodentaljournal@unissula.ac.id
apps